- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/10 - Ophthalmic agents for accommodation disorders, e.g. myopia
Patent holdings for IPC class A61P 27/10
Total number of patents in this class: 339
10-year publication summary
|
6
|
10
|
18
|
25
|
38
|
40
|
59
|
38
|
53
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 596 |
24 |
| Tsubota Laboratory, Inc. | 84 |
23 |
| Lenz Therapeutics Operations, Inc. | 38 |
17 |
| Allergan, Inc. | 2345 |
12 |
| The Trustees of Columbia University in the City of New York | 3577 |
9 |
| Singapore Health Services Pte Ltd | 472 |
9 |
| Opus Genetics, Inc. | 41 |
9 |
| University of Canberra | 22 |
8 |
| Rohto Pharmaceutical Co., Ltd. | 382 |
7 |
| University of Utah Research Foundation | 1810 |
7 |
| Eye Hospital, Wenzhou Medical University | 15 |
7 |
| University of Massachusetts | 2228 |
6 |
| Avedro, Inc. | 134 |
5 |
| Visus Therapeutics Inc. | 36 |
5 |
| ADS Therapeutics LLC | 40 |
5 |
| Wenzhou Medical University | 76 |
4 |
| Ocumension Therapeutics (Suzhou) Co., Ltd. | 10 |
4 |
| Alcon, Inc. | 5440 |
3 |
| Bodor Laboratories, Inc. | 58 |
3 |
| Keio University | 1097 |
3 |
| Other owners | 169 |